Institutional Perspectives in Cancer - Breast Cancer: Chaired by Erin Cobain, MD

Commentary
Article

In Partnership With:

Institutional Perspectives in Cancer - Breast Cancer: Chaired by Erin Cobain, MD

Institutional Perspectives in Cancer - Breast Cancer: Chaired by Erin Cobain, MD

The live filming of this virtual event in our IPC series is now on-demand.

OncLive is proud to present the State of the Science Summits and a new virtual event, Institutional Perspectives in Cancer (IPC). Each summit and webinar will convene for a short meeting designed to educate healthcare professionals on the clinical benefits associated with new science driving new thinking in cancer management. Attendees will not only improve their knowledge of novel treatment approaches, but also leave the event the with confidence and intent to apply state-of-the-art treatment strategies to care for their patients. Each event is dedicated to the latest research in one of the following therapeutic areas: Breast Cancer, Lung Cancer, GU & Prostate Cancer, Hematology, or Melanoma.

The State of the Science Summits and IPC assemble academic and community-based physicians & healthcare professionals across key disciplines from medical and surgical oncology. Specialist experts serve as faculty for these premier and renowned oncology summits, which focus on the most relevant cancer topics to ultimately improve patient care.

Speakers

  • Monika Burness, MD | University of Michigan Health
  • Julia Foldi, MD, PhD | UPMC Hillman Cancer Center
  • Margaret Gatti-Mays, MD, MPH, FACP | The Ohio State University Comprehensive Cancer Center
  • Jailan Elayoubi, MD | Karmanos Cancer Center
  • Dana Zackalik, MD | Oakland University William Beaumont School of Medicine
  • Erin Cobain, MD | University of Michigan Health

Topics

  • Use of CDK4/6 Inhibition in HR+, HER2- Breast Cancer
  • Use of ADCs in the Treatment of Metastatic Breast Cancer: Current Status and Future Directions
  • Treatment of HR+, HER2- mBC Beyond CDK4/6 Inhibitors: Novel ET and Targeted Therapy Approaches
  • Management of Early-Stage TNBC: Where Are We Now and Where Are We Going?
  • Management of HER2+ Breast Cancer
  • Updates in Breast Cancer Genetics

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Video 5 - "AE Management with CDK4/6 Inhibitors: Strategies for Treatment Continuity and Optimal Patient Outcomes"
Rita Nanda, MD
Siddartha Yadav, MD, FACP
Nan Chen, MD
Video 4 - "The Evolving Treatment Landscape with CDK4/6 Inhibitors in Early HR+/HER2- Breast Cancer"
Margaret E. Gatti-Mays, MD, MPH, FACP, of The Ohio State University Comprehensive Cancer Center
Ko Un “Clara” Park, MD
Erin Frances Cobain, MD
Video 3 - "5-Year Data from the MonarchE Trial Investigating Abemaciclib in HR+, HER2- High-Risk, Early Breast Cancer"
Carlos Arteaga, MD